Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 3
1993 9
1994 4
1995 4
1996 5
1997 5
1998 4
2000 3
2001 5
2002 4
2003 6
2004 4
2005 13
2006 9
2007 17
2008 13
2009 25
2010 8
2011 15
2012 15
2013 23
2014 18
2015 16
2016 12
2017 13
2018 17
2019 17
2020 16
2021 11
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

275 results

Results by year

Filters applied: . Clear all
Page 1
Socioeconomic status and breast cancer treatment.
Dreyer MS, Nattinger AB, McGinley EL, Pezzin LE. Dreyer MS, et al. Breast Cancer Res Treat. 2018 Jan;167(1):1-8. doi: 10.1007/s10549-017-4490-3. Epub 2017 Sep 7. Breast Cancer Res Treat. 2018. PMID: 28884392 Free PMC article. Review.
Mammaprint™: a comprehensive review.
Brandão M, Pondé N, Piccart-Gebhart M. Brandão M, et al. Future Oncol. 2019 Jan;15(2):207-224. doi: 10.2217/fon-2018-0221. Epub 2018 Aug 29. Future Oncol. 2019. PMID: 30156427
Prosigna test in breast cancer: real-life experience.
Hequet D, Harrissart G, Krief D, Maumy L, Lerebours F, Menet E, Callens C, Rouzier R. Hequet D, et al. Breast Cancer Res Treat. 2021 Jul;188(1):141-147. doi: 10.1007/s10549-021-06191-x. Epub 2021 Apr 15. Breast Cancer Res Treat. 2021. PMID: 33860387
The cost-effectiveness of adjuvant chemotherapy for early breast cancer: A comparison of no chemotherapy and first, second, and third generation regimens for patients with differing prognoses.
Campbell HE, Epstein D, Bloomfield D, Griffin S, Manca A, Yarnold J, Bliss J, Johnson L, Earl H, Poole C, Hiller L, Dunn J, Hopwood P, Barrett-Lee P, Ellis P, Cameron D, Harris AL, Gray AM, Sculpher MJ. Campbell HE, et al. Eur J Cancer. 2011 Nov;47(17):2517-30. doi: 10.1016/j.ejca.2011.06.019. Epub 2011 Jul 7. Eur J Cancer. 2011. PMID: 21741831
275 results